IIM
NVAX icon

INTECH Investment Management’s Novavax NVAX Stock Holding History

INTECH Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
43,278
-14,386
-25% -$129K ﹤0.01% 1433
2026
Q1 		$469K Sell
57,664
-49,638
-46% -$450K ﹤0.01% 1360
2025
Q4 		$721K Buy
107,302
+15,932
+17% +$120K 0.01% 1310
2025
Q3 		$792K Buy
91,370
+9,694
+12% +$75.4K 0.01% 1319
2025
Q2 		$515K Sell
81,676
-58,151
-42% -$385K ﹤0.01% 1598
2025
Q1 		$896K Buy
139,827
+65,801
+89% +$544K 0.01% 1270
2024
Q4 		$595K Buy
74,026
+32,275
+77% +$311K 0.01% 1455
2024
Q3 		$527K Buy
+41,751
New +$539K 0.01% 1199

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

INTECH Investment Management's NVAX Position: Q2 2026 in Review

INTECH Investment Management reduced its Novavax (NVAX) stake by 25% in Q2 2026, selling an estimated $129K and leaving 43,278 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

INTECH Investment Management first reported a position in NVAX in Q3 2024 and has held it in 8 quarters since. The position peaked at $896K in Q1 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • INTECH Investment Management held 43,278 shares of Novavax worth $408K as of Q2 2026.
  • INTECH Investment Management sold 14,386 Novavax shares in Q2 2026, an estimated $129K.
  • Novavax made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1433 holding.
  • INTECH Investment Management first reported a position in Novavax in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Novavax position peaked at $896K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.